QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)
CUSIP: 74754R103
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 6,138,804
- Total 13F shares
- 2,669,299
- Share change
- -61,693
- Total reported value
- $2,854,181
- Price per share
- $1.07
- Number of holders
- 25
- Value change
- -$109,633
- Number of buys
- 7
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74754R103:
Top shareholders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
19%
|
1,175,946
|
$1,529,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.4%
|
331,773
|
$432,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.6%
|
221,146
|
$287,000 | — | 30 Sep 2021 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
2.2%
|
137,510
|
$178,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
111,714
|
$145,000 | — | 30 Sep 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
107,500
|
$140,000 | — | 30 Sep 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.6%
|
100,045
|
$130,000 | — | 30 Sep 2021 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.3%
|
82,000
|
$107,000 | — | 30 Sep 2021 | |
| HighMark Wealth Management LLC |
13F
|
Company |
1.3%
|
80,094
|
$104,000 | — | 30 Sep 2021 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
1.3%
|
78,687
|
$102,000 | — | 30 Sep 2021 | |
| PERKINS CAPITAL MANAGEMENT INC |
13F
|
Company |
0.83%
|
51,178
|
$67,000 | — | 30 Sep 2021 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.71%
|
43,641
|
$57,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.7%
|
43,253
|
$56,000 | — | 30 Sep 2021 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.52%
|
32,228
|
$42,000 | — | 30 Sep 2021 | |
| HATTON CONSULTING, INC. |
13F
|
Company |
0.44%
|
27,195
|
$35,000 | — | 30 Sep 2021 | |
| Virtu Financial LLC |
13F
|
Company |
0.42%
|
25,507
|
$33,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.33%
|
20,282
|
$26,000 | — | 30 Sep 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.33%
|
20,060
|
$26,000 | — | 30 Sep 2021 | |
| CRA Financial Services, LLC |
13F
|
Company |
0.33%
|
19,957
|
$26,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.31%
|
18,879
|
$25,000 | — | 30 Sep 2021 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.25%
|
15,347
|
$20,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.21%
|
13,118
|
$17,000 | — | 30 Sep 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
0.15%
|
9,047
|
$12,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.12%
|
7,544
|
$10,000 | — | 30 Sep 2021 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.06%
|
3,428
|
$6,000 | — | 30 Sep 2021 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
1,000
|
$1,000 | — | 30 Sep 2021 | |
| Archer Investment Corp |
13F
|
Company |
0%
|
160
|
$208 | — | 30 Sep 2021 |
Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) as of Q4 2021
As of 31 Dec 2021,
QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,669,299 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, JPMORGAN CHASE & CO, COMMONWEALTH EQUITY SERVICES, LLC, FRANKLIN RESOURCES INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and HighMark Wealth Management LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
26
Q4 2021 holders
25
Holder diff
-1
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.